ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.590
+0.050 (3.25%)
Oct 29, 2025, 1:29 PM EDT - Market open
ALX Oncology Holdings Employees
ALX Oncology Holdings had 80 employees as of December 31, 2024. The number of employees increased by 8 or 11.11% compared to the previous year.
Employees
80
Change (1Y)
8
Growth (1Y)
11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,457,163
Market Cap
85.15M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 80 | 8 | 11.11% |
| Dec 31, 2023 | 72 | 14 | 24.14% |
| Dec 31, 2022 | 58 | 15 | 34.88% |
| Dec 31, 2021 | 43 | 20 | 86.96% |
| Dec 31, 2020 | 23 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ALXO News
- 6 days ago - ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference - GlobeNewsWire
- 26 days ago - ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewsWire
- 6 weeks ago - ALX Oncology Appoints Board Member Barbara Klencke, M.D., as Interim Chief Medical Officer - GlobeNewsWire
- 2 months ago - ALX Oncology to Participate in Upcoming Investor Conferences in September - GlobeNewsWire
- 2 months ago - ALX Oncology Doses First Patient in Phase 1 Dose Escalation Trial Evaluating ADC ALX2004 for the Treatment of EGFR-Expressing Solid Tumors - GlobeNewsWire
- 2 months ago - ALX Oncology Holdings Inc. (ALXO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - ALX Oncology to Report Second Quarter 2025 Financial Results on August 12, 2025 - GlobeNewsWire